216 related articles for article (PubMed ID: 11709398)
1. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Herring N; Zaman JA; Paterson DJ
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro.
Herring N; Paterson DJ
J Physiol; 2001 Sep; 535(Pt 2):507-18. PubMed ID: 11533140
[TBL] [Abstract][Full Text] [Related]
3. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
4. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
5. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
6. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF
Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
9. cGMP-dependent and -independent inhibition of a K+ conductance by natriuretic peptides: molecular and functional studies in human proximal tubule cells.
Hirsch JR; Meyer M; Mägert HJ; Forssmann WG; Mollerup S; Herter P; Weber G; Cermak R; Ankorina-Stark I; Schlatter E; Kruhøffer M
J Am Soc Nephrol; 1999 Mar; 10(3):472-80. PubMed ID: 10073597
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides.
Tolsa JF; Gao Y; Sander FC; Souici AC; Moessinger A; Raj JU
Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H273-80. PubMed ID: 11748072
[TBL] [Abstract][Full Text] [Related]
12. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
13. Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria.
Herring N; Golding S; Paterson DJ
J Mol Cell Cardiol; 2000 Oct; 32(10):1795-804. PubMed ID: 11013124
[TBL] [Abstract][Full Text] [Related]
14. Localization of natriuretic peptides and their activation of particulate guanylate cyclase and nitric oxide synthase in the retina.
Blute TA; Lee HK; Huffmaster T; Haverkamp S; Eldred WD
J Comp Neurol; 2000 Sep; 424(4):689-700. PubMed ID: 10931490
[TBL] [Abstract][Full Text] [Related]
15. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling.
Lee SJ; Kim SZ; Cui X; Kim SH; Lee KS; Chung YJ; Cho KW
Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H208-21. PubMed ID: 10644601
[TBL] [Abstract][Full Text] [Related]
17. Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells.
Cammarata PR; Braun B; Dimitrijevich SD; Pack J
Mol Vis; 2010 Apr; 16():630-8. PubMed ID: 20700369
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization.
Simon A; Harrington EO; Liu GX; Koren G; Choudhary G
Am J Physiol Lung Cell Mol Physiol; 2009 Feb; 296(2):L248-56. PubMed ID: 19036874
[TBL] [Abstract][Full Text] [Related]
19. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
Sabbatini ME; Rodríguez MR; Corbo NS; Vatta MS; Bianciotti LG
Eur J Pharmacol; 2005 Nov; 524(1-3):67-74. PubMed ID: 16263110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
